News brief
On 2026-03-16, according to Xiniu Data, Unnatural Products completed Series B financing, raising USD 45 million. Investors were Merck Global Health Innovation Fund, The Venture Collective, ARTIS Ventures.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年3月16日，据烯牛数据报道，Unnatural Products完成B轮融资，金额4500万美元。投资方为Merck Global Health Innovation Fund、The Venture Collective、ARTIS Ventures。